Neuropathic pain, a persistent and often debilitating condition caused by damage or dysfunction of the nervous system, affects millions of people worldwide. The pain can be excruciating and often resistant to conventional treatments. Mirogabalin, an α2δ ligand, has emerged as a promising therapeutic option for neuropathic pain, demonstrating efficacy in clinical trials and real-world settings. However, it is crucial to consider the unique pharmacokinetic and pharmacodynamic profiles of Mirogabalin in specific patient populations to ensure optimal efficacy and safety. https://www.qingmupharm.com/products/human-apis/mirogabalin-api